ANI Pharma (ANIP) Approves $25M Common Stock Buyback Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
ANI Pharmaceuticals Announces Board Authorization of Stock Repurchase Program
October 5, 2015 8:00 AM EDTBAUDETTE, Minn., Oct. 5, 2015 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP)  announced today that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $25 million of shares of the Company's common stock. ANI expects to fund the stock repurchase program through cash on hand. Â
The authorization allows for repurchases to be conducted through open market or through privately negotiated transactions through December 31, 2016. The number of shares repurchased and the timing of repurchases will depend on a number of factors, including, but not... More



